| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.25B | 22.05B | 21.70B | 38.46B | 27.92B | 22.23B |
| Gross Profit | 3.95B | 4.58B | 1.96B | 1.39B | 3.56B | 359.00M |
| EBITDA | 2.50B | 3.19B | 5.00M | -1.09B | 1.63B | -1.67B |
| Net Income | 1.19B | 1.78B | -1.22B | -2.37B | 444.00M | -2.88B |
Balance Sheet | ||||||
| Total Assets | 28.86B | 29.73B | 30.00B | 33.17B | 33.57B | 30.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.60B | 2.30B | 1.83B | 2.04B | 1.60B | 1.40B |
| Total Debt | 17.36B | 18.65B | 20.53B | 21.05B | 18.29B | 17.95B |
| Total Liabilities | 23.09B | 24.05B | 26.22B | 27.78B | 25.83B | 23.51B |
| Stockholders Equity | 5.77B | 5.67B | 3.78B | 5.39B | 7.74B | 7.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.79B | 471.00M | -1.98B | -29.00M | -3.77B |
| Operating Cash Flow | 0.00 | 2.94B | 1.41B | -1.63B | 666.00M | -2.37B |
| Investing Cash Flow | 0.00 | -149.00M | -495.00M | -339.00M | -680.00M | -1.23B |
| Financing Cash Flow | 0.00 | -2.37B | -1.11B | 2.42B | 198.00M | 3.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ― | ― | ― | ― | 8.57% | 15.83% | |
73 Outperform | ¥21.21B | 21.13 | ― | 4.66% | 13.76% | 13.58% | |
66 Neutral | ¥3.69B | 3.11 | ― | ― | -9.90% | 27.50% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | ¥203.18B | 12.56 | ― | 3.40% | -4.87% | 26.27% | |
64 Neutral | ¥64.86B | 21.29 | ― | 1.37% | -6.97% | ― | |
50 Neutral | ¥36.68B | ― | -32.70% | 2.52% | -19.99% | -243.54% |